Initial Dispute Resolution. Either Party may refer any dispute in connection with this Agreement (“Dispute”) not resolved by discussion of the BD/Contract Liaisons to senior executives of the Parties (for Adimab, its CEO or his designee and for Surface, its CEO or his designee) for good-faith discussions over a period of not less than sixty (60) days (the “Senior Executives Discussions”). Each Party will make its executives reasonably available for such discussions.
Appears in 4 contracts
Samples: Development and Option Agreement (Coherus BioSciences, Inc.), Development and Option Agreement (Surface Oncology, Inc.), Development and Option Agreement (Surface Oncology, Inc.)
Initial Dispute Resolution. Either Party may refer any dispute in connection with this Agreement (“Dispute”) not resolved by discussion of the BD/Contract Liaisons to senior executives of the Parties (for Adimab, its CEO or his designee and for SurfaceiTeos, its CEO or his designee) for good-faith discussions over a period of not less than sixty (60) days [***] (the “Senior Executives Discussions”). Each Party will make its executives reasonably available for such discussions.
Appears in 2 contracts
Samples: Collaboration Agreement (iTeos Therapeutics, Inc.), Collaboration Agreement (iTeos Therapeutics, Inc.)
Initial Dispute Resolution. Either Party may refer any dispute in connection with this Agreement (“Dispute”) not resolved by discussion of the BD/Contract Liaisons Alliance Managers to senior executives of the Parties (for Adimab, its CEO or his designee and for SurfaceScholar Rock, its CEO or his designee) for good-faith discussions over a period of not less than sixty (60) [***] days (the “Senior Executives Discussions”). Each Party will make its executives reasonably available for such discussions.
Appears in 1 contract
Samples: Collaboration Agreement (Scholar Rock Holding Corp)
Initial Dispute Resolution. Either Party may refer any dispute in connection with this Agreement (“Dispute”) not resolved by discussion of the BD/Contract Liaisons to senior executives of the Parties (for Adimab, its CEO or his designee and for SurfaceCheckpoint, its CEO or his designee) for good-faith discussions over a period of not less than sixty (60) days (the “Senior Executives Discussions”). Each Party will make its executives reasonably available for such discussions.
Appears in 1 contract
Samples: Collaboration Agreement (Checkpoint Therapeutics, Inc.)
Initial Dispute Resolution. Either Party may refer any dispute in connection with this Agreement (“Dispute”) not resolved by discussion of the BD/Contract Liaisons to senior executives of the Parties (for Adimab, its CEO or his designee and for SurfaceFlame, its CEO or his designee) for good-faith discussions over a period of not less than sixty (60) days [***] (the “Senior Executives Discussions”). Each Party will make its executives reasonably available for such discussions.
Appears in 1 contract
Initial Dispute Resolution. Either Party may refer any dispute in connection with this Agreement (“Dispute”) not resolved by discussion of the BD/Contract Liaisons Alliance Managers to senior executives of the Parties (for Adimab, its CEO CEO, or his or her designee and for SurfaceXxxxxxxx, its CEO CEO, or his or her designee) for good-faith discussions over a period of not less than sixty (60) days [***] (the “Senior Executives Discussions”). Each Party will make its executives reasonably available for such discussions.
Appears in 1 contract
Initial Dispute Resolution. Either Party may refer any dispute in connection with this Agreement (“Dispute”) not resolved by discussion of the BD/Contract Liaisons Alliance Managers to senior executives of the Parties (for Adimab, its CEO CEO, or his or her designee and for SurfaceAlector, its CEO CEO, or his or her designee) for good-faith discussions over a period of not less than sixty (60) days [***] (the “Senior Executives Discussions”). Each Party will make its executives reasonably available for such discussions.
Appears in 1 contract
Initial Dispute Resolution. Either Party may refer any dispute in connection with this Agreement (“Dispute”) not resolved by discussion of the BD/Contract Liaisons to senior executives of the Parties (for Adimab, its CEO or his designee and for SurfaceLeap, its CEO or his designee) for good-faith discussions over a period of not less than sixty (60) days [***] (the “Senior Executives Discussions”). Each Party will make its executives reasonably available for such discussions.
Appears in 1 contract
